Search

everythinglearnresearchcommunity

for

Search:↓

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Hirsutism causes significant psychological distress in women.

Androgens can both increase body hair and cause scalp hair loss.

Low prolactin in young women may increase heart and metabolism risks.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Finasteride may increase hair growth and prevent baldness in men, but can cause sexual side effects.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Finasteride improved symptoms in a schizophrenia patient.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

PCOS increases sexual pain distress in infertile women.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Hair changes could indicate neurological diseases and help monitor treatment.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.